While states are taking steps of their own to try and drive down prescription drug costs on a local level, pharmaceutical companies are fighting back.
According to a New York Times report, drugmakers are challenging the states’ laws, claiming the regulations are violating their constitutional rights.
So far, 24 states have pushed through 37 bills in 2018 to combat the current trend in drug prices, National Academy for State Health Policy Executive Director Trish Riley tells the Times.
“In the absence of federal action, states are taking the lead in combating high drug prices,” Connecticut State Rep. Sean Scanlon, a Democrat, said.
One popular strategy among states, according to the report, is requiring states to justify price increases for some drugs. Some pharmacy benefit managers are also being told to disclose rebates and other price concessions from drugmakers.
Click here to read the full report on the Times. (Paid subscription may be required)